Germany's Biotronik has treated its first patient in a multi-center trial of its bioabsorbable vascular scaffold, a study aimed at winning a CE mark for the coronary artery disease-treating device.
Germany's Biotronik is rolling out a new line of implantable cardioverter defibrillators meant to be safe for MRI use, an advance that has proliferated in Europe. The Berlin-based cardiac device company will start selling its Idova 7 implantable cardioverter defibrillators, which it bills as the most powerful ICDs approved for MR scanning. Initial implants have taken place in Austria and Italy.
Germany's Biotronik is rolling out two longer lengths of one of its signature stents in a bid that could help it stand out in a very crowded field.
Germany's Biotronik says it's upping the ante in the ongoing industry race to release more MRI-safe defibrillators and pacers. The next weapon: more scanning options.
C.R. Bard is working hard to show the versatility of its Lutonix drug-coated balloon, even before it wins FDA approval. A few years after acquiring the technology in a $225 million grab of a company with the same name, the first human patient has joined a new trial testing the device below the knee.
St. Jude Medical gained a pivotal CE mark for two next-generation lines of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators, advancing in Europe even as its rivals win U.S. approval for competing devices.
Germany's Biotronik won the FDA's sign-off for its Ilesto line of cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D).
Cardiac rhythm management isn't exactly a growth industry. Across the world, medical device companies are dealing with stagnant demand, pricing pressures and reimbursement cuts for pacemakers and...
Biotronik got the FDA's final approval on Lumax 740 DX, a first-in-class single-lead ICD designed to treat atrial fibrillation that the company says could vastly improve care for patients.
Medtronic gained FDA approval for what will become its second MRI-friendly pacer in the United States, and only the second device of its kind to gain a regulatory nod here.